About us About us

Company profile


Shenzhen Techdow Pharmaceutical Co., Ltd (Techdow) was established in Jun 2004, located in Shenzhen High-tech Industrial Park where was treated as ‘World-class high-tech industrial park’ by Ministry of Science and Technology of China. Through more than 10 years of accumulation and innovation, Techdow has become a large Low Molecular Weight Heparin (LMWH) pharmaceutical enterprise including R&D, manufacture and sales. Techdow uphold the values of ‘Science, Research, Diligence, and Harmony’. Techdow has strong scientific research strength and industrialization capacity, which product has been sold into worldwide. Techdow has established the long term and stable cooperation with more than 50 well-known pharmaceutical companies.

Techdow is the largest LWMH manufacturer and exporter of China. Depending on the strong research strength, leading technology, reliable quality assurance system and excellent industrialization capacity, Techdow’s API product (such as Enoxaparin sodium API) has obtained the GMP certificate from more than 20 authorities including US FDA, EU, Australia TGA, Brazil ANVISA, Colombia INVIMA and so on, Furthermore, Techdow has passed US FDA inspection for API without any deficiency for twice.

Focusing on the business development of heparin and LMWH finished dosage; Techdow has currently become the largest LMWH finished dosage product exporter in China. In 2014, Techow’s Heparin Sodium injection got the US FDA ANDA, becoming the first Chinese Heparin Sodium Injection supplier in American market. In 2016, Techdow obtained marketing authorization of Enoxaparin Sodium injection in EU market, becoming the first Enoxaparin sodium injection generic supplier in EU market. In 2016, our product was launched in Poland, and Techdow UK, Techdow Germany and other European subsidiary were established simultaneously. In 2017, our product was launched in Germany, UK and Italy, the sales volume and market share have been increasing since then, based on the sales channel construction and development and unique product advantages. With its highly efficient and large R & D structure, Techdow has become the cradle of high-quality pharmaceutical products, which further takes its social responsibility for customers, employees, investors and governments through their products and services. Techdow dedicates to become a respectable globalization pharmaceutical enterprise, and make a great contribution to human health.   

Hot Products / Hot products
Hot News / Hot news
2016 - 06 - 01
Clicks: 1547
Jun 01 2016, Poland Food and Drug Administration (hereinafter referred to as SPDA) issued GMP inspection certificate: Shenzhen Techdow pharmaceutical Co,.Ltd. Pharmaceutical production was&#...
Dynamic / News More
  • 1
    2016 - 05 - 07
    On the afternoon of May 7th, 2016, the list of winners of the 13th “Shenzhen Top Brand” was revealed in the 13th “Shenzhen Top Brand” Achievement Conference which was held by the Appraisal Committee of “Shenzhen Top Brand”. Our company was awarded the title of “Shenzhen Top Brand”. We had participated in the appraisal activity of “Shenzhen Top Brand” since December 2nd, 2015 and the brand of “Techdow” possessed by the company was finally awarded the title of “Shenzhen Top Brand” after the careful appraisal by the the Appraisal Committee...
Copyright ©2016 - 2019 Shenzhen Techdow Pharmaceutical Co., Ltd   粤ICP备17002692号  
Communication 老客户专线:0755-2955 6666(24)
图文传真:0755 - 27 888 009
服务投拆:0755-2775 9293 (客服服务态度质量监视、意见反馈)
总机电话:0755-2775 9293
彩文传真:0755-27 888 009 (两线)
  • Mobile
  • WeChat public